Why US Medicare Drug Price Assessments And Negotiations Should Not Use Canada As A Model healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.
Approval is based on results from three Phase 3 studies: two for induction and one for maintenance 1,2,3In clinical trials, patients taking RINVOQ achieved the primary endpoint of clinical remission .
/CNW Telbec/ - AbbVie (NYSE: ABBV) announced today that Health Canada has approved QULIPTA (atogepant) for the prevention of episodic migraine (< 15 migraine.
Timing of elimination of the hepatitis C virus (HCV) in Canada s provinces indicates 70% of provinces could reach the World Health Organization s (WHO) HCV.